Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie C Friedland

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|January 31, 2009
Mechanically activated integrin switch controls alpha5beta1 functionJulie C Friedland, Mark H Lee, David Boettiger
Journal of Neurotrauma|July 16, 2004
Traumatic brain injury elevates glycogen and induces tolerance to ischemia in rat brainTatsuo Otori, Julie C Friedland, Grant Sinson, et al.
Journal of Cell Science|October 4, 2007
alpha6beta4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-kappaB-dependent resistance to apoptosis in 3D mammary aciniJulie C Friedland, Johnathon N Lakins, Marcelo G Kazanietz, et al.
Investigational New Drugs|May 21, 2013
Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypesJulie C Friedland, Donald L Smith, Jim Sang, et al.
Molecular Cancer Therapeutics|September 27, 2012
Targeting KRAS-mutant non-small cell lung cancer with the Hsp90 inhibitor ganetespibJaime Acquaviva, Donald L Smith, Jim Sang, et al.
International Journal of Oncology|November 16, 2012
Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expressionSuqin He, Chaohua Zhang, Ayesha A Shafi, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2004
Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitorsJohn F Cryan, Olivia F O'Leary, Sung-Ha Jin, et al.
Melanoma Research|May 13, 2022
Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanomaZachary Wolfe, Julie C Friedland, Sarah Ginn, et al.
Cancer Discovery|March 28, 2013
Targeted inhibition of the molecular chaperone Hsp90 overcomes ALK inhibitor resistance in non-small cell lung cancerJim Sang, Jaime Acquaviva, Julie C Friedland, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|January 31, 2009
Mechanically activated integrin switch controls alpha5beta1 functionJulie C Friedland, Mark H Lee, David Boettiger
Journal of Neurotrauma|July 16, 2004
Traumatic brain injury elevates glycogen and induces tolerance to ischemia in rat brainTatsuo Otori, Julie C Friedland, Grant Sinson, et al.
Journal of Cell Science|October 4, 2007
alpha6beta4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-kappaB-dependent resistance to apoptosis in 3D mammary aciniJulie C Friedland, Johnathon N Lakins, Marcelo G Kazanietz, et al.
Investigational New Drugs|May 21, 2013
Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypesJulie C Friedland, Donald L Smith, Jim Sang, et al.
Molecular Cancer Therapeutics|September 27, 2012
Targeting KRAS-mutant non-small cell lung cancer with the Hsp90 inhibitor ganetespibJaime Acquaviva, Donald L Smith, Jim Sang, et al.
International Journal of Oncology|November 16, 2012
Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expressionSuqin He, Chaohua Zhang, Ayesha A Shafi, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2004
Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitorsJohn F Cryan, Olivia F O'Leary, Sung-Ha Jin, et al.
Melanoma Research|May 13, 2022
Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanomaZachary Wolfe, Julie C Friedland, Sarah Ginn, et al.
Cancer Discovery|March 28, 2013
Targeted inhibition of the molecular chaperone Hsp90 overcomes ALK inhibitor resistance in non-small cell lung cancerJim Sang, Jaime Acquaviva, Julie C Friedland, et al.
Pageof 1